SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-21-000168
Filing Date
2021-08-03
Accepted
2021-08-03 07:37:21
Documents
15
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20210803.htm   iXBRL 8-K 63264
2 EX-99.1 q221lillysalesandearningsp.htm EX-99.1 448002
7 logoa31a.jpg GRAPHIC 14287
  Complete submission text file 0000059478-21-000168.txt   798365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20210803.xsd EX-101.SCH 4013
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20210803_def.xml EX-101.DEF 18480
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20210803_lab.xml EX-101.LAB 38670
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20210803_pre.xml EX-101.PRE 19470
8 EXTRACTED XBRL INSTANCE DOCUMENT lly-20210803_htm.xml XML 25252
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 211137999
SIC: 2834 Pharmaceutical Preparations